The findings reported here for antihypertensive treatment effects of seven AGT SNPs in 2253 CHD cases and 1728 HF cases suggest that a patient's AGT variants might help predict which hypertensive medication(s) can lower cardiovascular disease risk. The gene discussed is AGT; the disease is hydrops fetalis.